Omnicell Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Omnicell de 39.7% y 3.9% respectivamente, mientras que el BPA crecerá en un 38.3% al año.

Información clave

39.7%

Tasa de crecimiento de los beneficios

38.31%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	13.4%
Tasa de crecimiento de los ingresos	3.9%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Good
Última actualización	19 Dec 2025

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Improved Revenues Required Before Omnicell, Inc. (NASDAQ:OMCL) Stock's 25% Jump Looks Justified

Nov 13

Omnicell Q2 Earnings: Market Ignoring The Segments

Jul 31

Omnicell (NASDAQ:OMCL) May Have Issues Allocating Its Capital

Jul 16

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Jun 28

Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges

May 27 Supply chain improvements and near-shoring are expected to offset cost pressures, while a shift to recurring SaaS and services enhances earnings stability and valuation potential.

It Looks Like Omnicell, Inc.'s (NASDAQ:OMCL) CEO May Expect Their Salary To Be Put Under The Microscope

May 14

US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results

May 09

Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 09

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 26% Below Their Intrinsic Value Estimate

Jan 28

Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues

Nov 27

Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next

Nov 02

Omnicell Q3 Earnings: Look At The Growth Segment

Nov 01

Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Oct 31

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Oct 07

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Aug 02

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Jul 11

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Jun 16

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

May 25

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Feb 23

Omnicell Is Building A Strong Moat

Feb 22

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Jan 15

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:OMCL - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2028	1,323	N/A	75	N/A	1
12/31/2027	1,286	40	63	N/A	4
12/31/2026	1,235	29	47	N/A	8
12/31/2025	1,184	14	38	N/A	8
9/30/2025	1,178	20	94	153	N/A
6/30/2025	1,150	23	89	148	N/A
3/31/2025	1,136	21	108	164	N/A
12/31/2024	1,112	13	135	188	N/A
9/30/2024	1,064	-18	118	170	N/A
6/30/2024	1,080	-21	152	204	N/A
3/31/2024	1,103	-21	165	218	N/A
12/31/2023	1,147	-20	126	181	N/A
9/30/2023	1,186	-34	165	225	N/A
6/30/2023	1,235	-23	127	189	N/A
3/31/2023	1,268	-18	48	107	N/A
12/31/2022	1,296	6	17	78	N/A
9/30/2022	1,309	48	-5	55	N/A
6/30/2022	1,258	61	18	77	N/A
3/31/2022	1,199	72	98	158	N/A
12/31/2021	1,132	78	173	232	N/A
9/30/2021	1,070	80	195	249	N/A
6/30/2021	987	60	194	242	N/A
3/31/2021	914	35	164	218	N/A
12/31/2020	892	32	131	186	N/A
9/30/2020	891	38	86	144	N/A
6/30/2020	906	49	101	164	N/A
3/31/2020	924	69	85	144	N/A
12/31/2019	897	61	83	145	N/A
9/30/2019	860	54	98	158	N/A
6/30/2019	836	48	N/A	117	N/A
3/31/2019	807	38	N/A	112	N/A
12/31/2018	787	38	N/A	104	N/A
9/30/2018	772	54	N/A	61	N/A
6/30/2018	754	48	N/A	27	N/A
3/31/2018	747	44	N/A	16	N/A
12/31/2017	713	31	N/A	25	N/A
9/30/2017	688	-1	N/A	45	N/A
6/30/2017	678	-6	N/A	72	N/A
3/31/2017	670	-9	N/A	56	N/A
12/31/2016	696	10	N/A	50	N/A
9/30/2016	651	8	N/A	54	N/A
6/30/2016	599	14	N/A	40	N/A
3/31/2016	539	24	N/A	44	N/A
12/31/2015	485	31	N/A	38	N/A
9/30/2015	476	32	N/A	37	N/A
6/30/2015	463	32	N/A	50	N/A
3/31/2015	455	31	N/A	75	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (39.7% al año) de OMCL es superior a la tasa de ahorro (3.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (39.7% al año) de OMCL crezcan más rápidamente que el mercado US (16.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de OMCL crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.9% al año) de OMCL crezcan más despacio que el mercado de US (10.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.9% al año) de OMCL crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de OMCL se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2025/12/31 07:44
Precio de las acciones al final del día	2025/12/30 00:00
Beneficios	2025/09/30
Ingresos anuales	2024/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Omnicell, Inc. está cubierta por 21 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
William Sutherland	Benchmark Company
Raymond Myers	Benchmark Company
Zhilin Long	Berenberg

Omnicell Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 8.8% to US$51.50

Price target increased by 7.6% to US$47.33

Omnicell, Inc. Updates Earnings Guidance for the Full Year 2025

Consensus EPS estimates have been upgraded.

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Updated Full Year 2025

Consensus EPS estimates upgraded to US$0.04 loss

Recent updates

Price target increased by 8.8% to US$51.50

Omicell, Inc. Announces the Launch of Omnicell Titan XT

Executive VP notifies of intention to sell stock

Now 20% undervalued

Improved Revenues Required Before Omnicell, Inc. (NASDAQ:OMCL) Stock's 25% Jump Looks Justified

Price target increased by 7.6% to US$47.33

Third quarter 2025 earnings: EPS and revenues exceed analyst expectations

Omnicell, Inc. Updates Earnings Guidance for the Full Year 2025

Omnicell, Inc. to Report Q3, 2025 Results on Oct 30, 2025

Now 20% undervalued

Omnicell, Inc. Appoints Baird Radford as Chief Financial Officer, Effective August 26, 2025

Consensus EPS estimates have been upgraded.

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Omnicell Q2 Earnings: Market Ignoring The Segments

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Updated Full Year 2025

Consensus EPS estimates upgraded to US$0.04 loss

Omnicell (NASDAQ:OMCL) May Have Issues Allocating Its Capital

Omnicell, Inc. to Report Q2, 2025 Results on Jul 31, 2025

Consensus EPS estimates upgraded to US$0.0025 loss

Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 2000 Value-Defensive Index

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges

Consensus EPS estimates upgraded to US$0.10 loss

Price target increased by 7.2% to US$39.83

Omnicell, Inc. (NasdaqGS:OMCL) announces an Equity Buyback for $75 million worth of its shares.

Omnicell, Inc. Announces New Products Designed to Streamline Workflows and Enhance Inventory Visibility and Management in Perioperative and Clinic Settings

Investor sentiment improves as stock rises 17%

It Looks Like Omnicell, Inc.'s (NASDAQ:OMCL) CEO May Expect Their Salary To Be Put Under The Microscope

US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results

Now 21% undervalued after recent price drop

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Omnicell, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2025

Omnicell, Inc. to Report Q1, 2025 Results on May 06, 2025

Omnicell (NASDAQ:OMCL) Seems To Use Debt Rather Sparingly

Omnicell, Inc., Annual General Meeting, May 21, 2025

Omnicell, Inc. Appoints Perry A. Genova as Senior Vice President, Chief Technology Officer, Effective March 31, 2025

Founder recently bought US$350k worth of stock

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025

Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem

Omnicell Q4 Earnings: Ignore The Short-Term Noise

Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

New minor risk - Earnings quality

Full year 2024 earnings: EPS exceeds analyst expectations

Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year of 2025

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 26% Below Their Intrinsic Value Estimate

Omnicell, Inc. to Report Q4, 2024 Results on Feb 06, 2025

Independent Director recently sold US$568k worth of stock

Independent Director notifies of intention to sell stock

Omnicell, Inc. Announces OmniSphere

Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues

Now 22% undervalued after recent price drop

Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next

Omnicell, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024

Omnicell Q3 Earnings: Look At The Growth Segment

Price target increased by 22% to US$54.71

Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Price target increased by 7.5% to US$45.00

Omnicell, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Omnicell, Inc. Announces Central Med Automation Service

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 17% to US$38.29

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024

Omnicell, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Now 20% undervalued